Harvard Bioscience
HBIO
81 hedge funds and large institutions have $82.2M invested in Harvard Bioscience in 2015 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 38 increasing their positions, 19 reducing their positions, and 10 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 38 | Existing positions reduced: 19
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
4% less funds holding
Funds holding: 84 → 81 (-3)
6% less capital invested
Capital invested by funds: $87.8M → $82.2M (-$5.53M)
30% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 10
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HA
Heartland Advisors
Milwaukee,
Wisconsin
|
+$3.42M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.05M |
| 3 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
+$692K |
| 4 |
WIC
Woodmont Investment Counsel
Nashville,
Tennessee
|
+$544K |
| 5 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$404K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PAIM
Punch & Associates Investment Management
Edina,
Minnesota
|
-$1.36M |
| 2 |
RHJA
Rice Hall James & Associates
San Diego,
California
|
-$1.19M |
| 3 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$1.06M |
| 4 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
-$991K |
| 5 |
GC
Globeflex Capital
San Diego,
California
|
-$668K |
HBIO Hedge Fund Activity: Q4 2015 in Review
81 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Harvard Bioscience (HBIO) for Q4 2015, worth a combined $82.2M — down 6.3% from $87.8M a quarter earlier.
Sellers outnumbered buyers: 10 funds closed out of HBIO and 7 opened new positions — a net loss of 3 holders — while 19 trimmed existing stakes and 38 added.
The largest buyer was Heartland Advisors, adding an estimated $3.42M. The largest seller was Punch & Associates Investment Management, exiting entirely with an estimated $1.36M sold.
- 81 institutional investors held Harvard Bioscience (HBIO) as of Q4 2015, down from 84 in Q3 2015.
- Funds reported $82.2M of Harvard Bioscience stock for Q4 2015, down 6.3% quarter-over-quarter.
- 7 funds opened new Harvard Bioscience positions in Q4 2015 and 10 closed out, a net change of -3 holders.
- The largest Harvard Bioscience buyer in Q4 2015 was Heartland Advisors, an estimated $3.42M added.
- The largest Harvard Bioscience seller in Q4 2015 was Punch & Associates Investment Management, an estimated $1.36M sold.
Based on aggregated 13F filings for Q4 2015.